DJIA 17,329.69 63.70 0.37%
NASDAQ 4,606.83 13.41 0.29%
S&P 500 2,014.62 3.26 0.16%
market minute promo

Epizyme (NASDAQ: EPZM)

27.62 0.28 (1.02%)

Quote as of


company name or ticker

Recent Quotes

EPZM $27.62 1.02%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.54
Previous Close $27.34
Daily Range $27.04 - $27.72
52-Week Range $18.10 - $42.71
Market Cap $927.6M
P/E Ratio 28.19
Dividend (Yield) $0.00 (0.0%)
Volume 27,409
Average Daily Volume 393,694
Current FY EPS -$1.68

Sector

Industry

Epizyme (EPZM) Description

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. Website: http://www.epizyme.com/

News & Commentary Rss Feed

Why Epizyme Inc. Shares Rocketed Higher

Epizyme shares soar after the company reaches another creative milestone with partner GlaxoSmithKline.

UPDATE: Mizuho Securities USA Initiates Coverage On Epizyme Inc On Epigenetics Pure Play

Benzinga's Top Initiations

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

Why Epizyme (EPZM) Stock Might be a Great Pick - Tale of the Tape

Epizyme, Inc. Announces Resignation Of President And CFO Jason Rhodes

Epizyme Announces Resignation Of President And CFO Jason Rhodes

InsiderInsights.com Daily Round Up 8/28/14: Republic Services, OPKO Health, Saba Software And OFS Ca

InsiderInsights.com Daily Round Up 8/28/14: Republic Services, OPKO Health, Saba Software And OFS Capital

Monday Sector Leaders: Biotechnology, Drugs

Epizyme: Strong Early Data But Reserving Judgment Until Final Results

Zacks' Bull Of The Day: Epizyme

Kindred Biosciences (KIN) in Focus: Stock Tanks 28.2% - Tale of the Tape

See More EPZM News...